Geovax Labs Inc (GOVX)
2.26
+0.05
(+2.26%)
USD |
NASDAQ |
Dec 24, 16:00
Geovax Labs Cash from Investing (Quarterly): -0.0207M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 112.00M |
| SIGA Technologies Inc | -0.0224M |
| Aethlon Medical Inc | 0.00 |
| Tonix Pharmaceuticals Holding Corp | -0.009M |
| Chimerix Inc | 28.32M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.297M |
| Cash from Financing (Quarterly) | 16.35M |
| Free Cash Flow | -27.24M |
| Free Cash Flow Per Share (Quarterly) | -1.455 |
| Free Cash Flow to Equity (Quarterly) | -9.176M |
| Free Cash Flow Yield | -362.7% |